Annual Medicaid price increase in top selling U.S. drugs 2014-2018
Between 2014 and 2018, the Medicaid price of Opdivo increased by 26 percent annually on average, along with a 16 percent average annual increase of Humira in the same time period. This statistic illustrates the percentage of annual Medicaid price increases of the top selling drugs in the United States.